Cerebral infarction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All the patients were diagnosed as ischemic stroke by CT or MRI; 2. The NIHSS scores of patients ranged from 3 to 15(including 3 and 15); 3. Aged 40 to 80 years; 4. The patient's onset is less than 72 hours; 5. The trial was informed consent of the patient or the patient's family or their legal representative and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who have received or are about to undergo endovascular interventional therapy (including arterial thrombolysis, bridging, mechanical thrombectomy, angioplasty and stenting); 2. Tests confirmed patients with brain trauma, brain tumors, brain parasitosis, and other brain disorders, or with immune system disorders; 3. The score of the modified Rankin scale (Rankin scale) was more than 2; 4. Patients with malignant tumor, CACHEXIA, moderate or severe malnutrition (albumin 80 U/L, The male Serum Creatinine >266 umol /L,The female Serum Creatinine >212 Umol/L); 6. Patients with other effects on limb function and limb function disorders affect the neurological examination; 7. Other diseases or mental disorders that the researchers believe may limit neurologic assessment or affect patient follow-up; 8. Pregnant or lactating women; 9. Patients undergoing clinical trials for other drugs; 10. Patients with contraindications to the drug therapy used in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum S100B;neuron-specific enolase (NSE); | — |
Countries
China
Contacts
Chongqing Traditional Chinese Medicine Hospital